Bulk lipase for chiral resolution in API process development
Chiralift supplies bulk lipase for chiral resolution programs where process chemists need selectivity, route compatibility, documentation, and dependable scale-up supply.
As a bulk enzyme supplier for pharmaceutical biocatalysis, we support API manufacturers evaluating lipase-catalyzed kinetic resolution, desymmetrization, ester hydrolysis, transesterification, and acylation steps for chiral alcohols, amines, acids, and ester intermediates.
Our role is practical: help you identify a lipase format that fits your substrate, solvent system, impurity profile, workup strategy, and commercial manufacturing expectations.
Where lipase resolution fits in an API route
Lipase biocatalysis is often considered when a route requires high enantioselectivity without adding unnecessary protecting-group burden, precious-metal dependency, or harsh reaction conditions.
Typical API process objectives include:
- Resolving racemic intermediates into the required enantiomer
- Improving enantiomeric purity before downstream API-forming steps
- Reducing chiral chromatography reliance
- Simplifying impurity purge strategy through cleaner selectivity
- Supporting milder conditions for sensitive functional groups
- Creating a more scalable alternative to classical resolution chemistry
Chiralift supports early route screening through supply for pilot and commercial-enabling batches.
Lipase options for route-fit screening
Different lipases can show distinct selectivity against the same substrate. Chiralift helps teams compare candidates based on process-relevant criteria rather than catalog generalities.
Evaluation factors
- Substrate class and steric environment
- Desired reaction direction: hydrolysis, esterification, transesterification, or acylation
- Solvent tolerance and water control requirements
- Temperature and pH compatibility within route constraints
- Immobilized versus non-immobilized process fit
- Reuse potential where immobilized formats are appropriate
- Downstream removal and filtration behavior
- Impurity formation, purge, and analytical burden
The goal is not simply to find a reactive enzyme. The goal is to identify a lipase that can survive the full process argument: yield, selectivity, impurity control, workup, documentation, and supply.
Built for pharmaceutical process expectations
API manufacturers need more than promising screening material. Chiralift supports enzyme procurement with documentation and supply practices aligned to regulated development environments.
Available documentation may include, as applicable:
- Certificate of analysis
- Safety data sheet
- Lot and batch traceability information
- Manufacturing origin and material statement support
- Storage and handling guidance
- Change-notification discussion for qualified supply
- Technical data package support for internal evaluation
We understand that enzyme adoption must withstand process development review, quality review, procurement review, and scale-up risk assessment.
Selectivity and impurity control
For chiral resolution, the enzyme choice directly affects more than enantiomeric outcome. It can influence unreacted starting material, overreaction, ester migration, hydrolysis byproducts, solvent-derived impurities, and downstream isolation behavior.
Chiralift helps API teams define the supply and screening scope around questions such as:
- Which lipase candidates show the most route-relevant selectivity?
- Does the reaction support the target impurity profile?
- Can the enzyme be removed cleanly during workup?
- Is the immobilized support compatible with process solvents?
- Can the selected grade be supplied consistently beyond lab screening?
This validation-aware approach helps reduce the risk of selecting an enzyme that performs in a vial but fails in a plant-ready process.
Scale-up support for bulk lipase procurement
Chiralift supports bulk procurement planning from development to larger campaign requirements.
Supply considerations we help clarify
- Target annual or campaign demand
- Preferred packaging and storage conditions
- Lot reservation and batch planning
- Lead time and replenishment expectations
- Documentation required by quality and procurement teams
- Technical questions for route transfer or site qualification
For API manufacturers, supply continuity is a process parameter. We treat it accordingly.
Typical applications
Chiralift bulk lipases are considered for API intermediate processes involving:
- Chiral secondary alcohol resolution
- Ester hydrolysis for enantiomer enrichment
- Selective acylation of racemic alcohols or amines
- Desymmetrization of prochiral diesters
- Preparation of enantioenriched building blocks
- Route improvement where chemical resolution is inefficient
If your team is comparing enzymatic resolution against salt resolution, chiral chromatography, or asymmetric synthesis, we can help structure the enzyme supply discussion around process fit.
Request a quote
Share your substrate class, desired transformation, target scale, preferred enzyme format, documentation needs, and expected timeline. Chiralift will respond with a bulk lipase supply path suited to your API development stage.
